Armata Pharmaceuticals, Inc.
Biotechnology-Research
Website
Company Tagline
PURPOSEFUL. PRECISE. POWERFUL.
Industry Category
Business Keywords
Company Description
Armata Pharmaceuticals, Inc. is a clinical-stage biotechnology company dedicated to the development of precisely targeted bacteriophage therapeutics. Focusing on treating antibiotic-resistant and difficult-to-treat bacterial infections, Armata Pharmaceuticals, Inc. utilizes its proprietary bacteriophage-based technology to create innovative solutions in the medical field.
Located at 5005 McConnell Ave, Los Angeles, California 90066, US, Armata Pharmaceuticals, Inc. is advancing a broad pipeline of both natural and synthetic phage candidates. These include clinical candidates specifically designed for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. Armata Pharmaceuticals, Inc. is deeply committed to enhancing phage technology with comprehensive drug development expertise that spans from the laboratory bench to clinical application, including in-house phage-specific cGMP manufacturing capabilities.
Armata Pharmaceuticals, Inc. is dedicated to pioneering advancements in biotechnology research. With a strong focus on targeted antimicrobials and drug development, Armata Pharmaceuticals, Inc. continues to drive innovation in the treatment of infectious diseases. We invite the management team to create a customized and exclusive company showcase and product listing on our platform to further highlight Armata Pharmaceuticals, Inc.'s groundbreaking work.
Armata Pharmaceuticals, Inc. est une société de biotechnologie en phase clinique dédiée au développement de traitements bactériophagiques précisément ciblés. En se concentrant sur le traitement des infections bactériennes résistantes aux antibiotiques et difficiles à traiter, Armata Pharmaceuticals, Inc. utilise sa technologie exclusive basée sur les bactériophages pour créer des solutions innovantes dans le domaine médical.
Située au 5005 McConnell Ave, Los Angeles, Californie 90066, États-Unis, Armata Pharmaceuticals, Inc. fait progresser un large éventail de candidats phages naturels et synthétiques. Ceux-ci incluent des candidats cliniques spécifiquement conçus pour Pseudomonas aeruginosa, Staphylococcus aureus et d'autres agents pathogènes. Armata Pharmaceuticals, Inc. s'engage pleinement à améliorer la technologie des phages grâce à une expertise complète en développement de médicaments, allant du laboratoire à l'application clinique, y compris des capacités de fabrication cGMP spécifiques aux phages en interne.
Armata Pharmaceuticals, Inc. se consacre aux avancées pionnières dans la recherche biotechnologique. En mettant l'accent sur les antimicrobiens ciblés et le développement de médicaments, Armata Pharmaceuticals, Inc. continue de stimuler l'innovation dans le traitement des maladies infectieuses. Nous invitons l'équipe de direction à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme afin de mettre davantage en évidence le travail révolutionnaire d'Armata Pharmaceuticals, Inc.
Key Personnel / Employees
Compare Companies Side by Side
Compare Armata Pharmaceuticals, Inc. with 3 companies in Biotechnology-Research
| Comparison Field |
Armata Pharmaceuticals, I...Main Company |
Locus Biosciences, I...View Profile |
Am
AmpliPhi BiosciencesView Profile |
Koliber BiosciencesView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2015 | 2014 | |
|
Company Size
|
— | 51-200 | 11-50 | 2-10 |
|
City
|
Los Angeles, California | Morrisville, North Carolina | Marina del Rey, California | San Diego, CA |
|
Country
|
United States | United States | United States | United States |
|
Skills & Keywords
Comparing with main company
|
18 Total Skills
Biotechnology
Pharmaceuticals
Bacteriophage Therapeutics
Drug Development
Antimicrobial Research
Infectious Disease Treatment
Clinical-Stage Biotechnology
Clinical-Stage
Therapeutics
targeted phage-based drugs
Engineered Phage
Targeted Antimicrobials
Phage
antimicrobial peptides
Bacteriophage
Synthetic Biology
Microbiome
Infectious Disease
|
6 Total
6 Unique
Unique Skills:
Antibiotic Resistance
Artificial Intelligence
Automation
Bacterial Infections
Immunology
Targeted Therapeutics
|
4 Total
4 Unique
Unique Skills:
Antibiotic Resistance
Anti-infectives
Antimicrobial resistance
Phage Therapy
|
8 Total
8 Unique
Unique Skills:
Artificial Intelligence
Data Science
Drug Discovery
Machine Learning
Peptides
Probiotics
+2
|
4
Total Companies2014
Oldest Founded1
Countries34
Unique SkillsSimilar Companies
Other organizations in the same industry
Resilient Biotics
Biotechnology-ResearchHarnessing the power of the respiratory microbiome
Benno Therapeutics
Biotechnology-ResearchDeveloping a Novel Treatment of Urothelial Cancer of the Bladder in Dogs
Allegro Biotech
Biotechnology-ResearchRegenerative Biomedical Technology
Concinnity Genetics
Biotechnology-ResearchImproving the safety and efficacy of gene therapies using AI
Alternative Company Names
This company is also known as